FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Saturday

 

CRT-300.04 Does An Endovascular Procedure Improve the Quality of Life in Patients With MS: STUDY
























Image Source: PINTEREST


Abstract

Background:
A vascular role in the etiology of multiple sclerosis (MS) has long been discussed. The extracranial stenoses of the jugular (IJV) and azygous (AZY) veins affect the venous drainage as chronic cerebrospinal venous insufficiency (CCSVI). The correlation between MS and CCSVI endeavour to elucidate the role of CCSVI and its influence on the symptoms and the signs of MS.

The primary endpoint of our open-label study was to evaluate quality of life (QoL) of MS patients with CCSVI after the endovascular procedures.

Methods:
MS patients were diagnosed by revised McDonald criteria and CCSVI was evaluated by Doppler sonography if 2 or more out of 5 criteria were observed. In patients with suspecting CCSVI the catheter venography was performed. To assess the efficacy of the vascular procedures on QoL, Fatigue Severity Scale (FSS), Modified Fatigue Impact Scale (MFIS), validated Overactive bladder self-administered questionnaire (OAB-V8 Pfizer) and Multiple Sclerosis Impact Scale (MSIS-29) were used. FSS, MFIS,OAB-V8 and MSIS-29 were evaluated at baseline, 3, 6, and 12 months after vascular angioplasty.

Results:
In our study 94 consecutive MS patients were included (22 patients with relapsing-remitting, 44 with secondary and 26 with primary progressive course of MS). In two patients (2.1%) venography did not reveal any vascular abnormality. The left IJV was more often affected. The number of venous lesions increases with the degree of disability (p < 0.02). FSS (p < 0.001) and MFIS scores - total score, as well as scores of the three subscales - physical, cognitive and psychosocial significantly improved from baseline values estimated before vascular procedures (p < 0.05). The improvement of the both scales correlated with the degree of pyramidal involvement (p < 0.001). The important improvement of the bladder function using OAB-V8 was demonstrated (p < 0.01). The improvement of QoL assessed by MSIS-29 questionnaire was observed (p < 0.01). The positive trend of all 4 parameters was maintained at one year.

Conclusion:
The amelioration of cerebral venous drainage reduce bladder disfunction, the perception of fatigue and increase mental health. Endovascular procedures in MS patients are beneficial and importantly contribute to the improvement of disability and quality of life in MS patients.

Story Source: The above story is based on materials provided by JACCJOURNALS
Note: Materials may be edited for content and length

Labels: ,



Go to Newer News Go to Older News